Commercialization

Our OTC products are competitive on the global market and address unmet needs. We seek long-term partnerships with established companies outside of the core Medis region. Our aim is achieve commercial success by combining our unique product range with your marketing and sales expertise.

To explore partnership opportunities, contact our international OTC business team:

T: +386 1 589 69 91
E: commercialization(at)medis.si

Our portfolio

Rosacta/Rowiren® - Pain Relief

Rowiren® Cream is the only herbal medicine with a maximum 10% rosemary essential oil content, providing the most efficient and safe way to topical pain relief. Due to the unique mode of action – analgesic effects and increased peripheral circulation – Rowiren® Cream quickly relieves muscles and joint pain, promoting the healing process without tiring the body. Rowiren® Cream has already been registered in 21 European countries and is immediately available for commercialization, with more to come soon.

Ask for a product leaflet now


Ladiva® - Menstrual Pain Relief

Ladiva® is the first and only herbal medicine for the relief of minor spasms associated with menstrual periods. Women benefit from a maximum amount of API with no known undesirable effects. It represents an effective solution to improve the quality of life of women during the menstrual period, in a completely natural way. Ladiva® is immediately available for commercialization in 13 European countries, with more to come soon.

Ask for product leaflet now


Calmia® - Oncology/dermatology treatment

Calmia® is an innovative cream to treat the acne-like rashes and hand-foot syndrome that occur in oncology treatments. The active ingredients are the inhibitors of epidermal growth factor receptors and chemotherapeutics.

The timely use of Calmia® prevents and eliminates skin conditions and allows patients to continue oncological treatment without interruptions. Calmia® is immediately available for commercialization worldwide.

Ask for product leaflet now